NAT PUBLIC HEALTH INST has a total of 14 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Canada, China and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are RYOGEN LLC, MICROMEDMARK BIOTECH CO LTD and ZHANG CHENYU.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 2 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Hong Kong | 1 | |
#7 | Israel | 1 | |
#8 | Mexico | 1 | |
#9 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Agriculture | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Measuring microorganism processes | |
#3 | Medical preparations | |
#4 | Animal care | |
#5 | Enzymes | |
#6 | Microorganisms | |
#7 | Peptides | |
#8 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Peltonen Leena | 8 |
#2 | Terwilliger Joseph | 6 |
#3 | Sahi Timo | 6 |
#4 | Savilahti Erkki | 6 |
#5 | Enattah Nabil | 6 |
#6 | Jaervelae Irma | 6 |
#7 | Taskinen Marja-Riita | 3 |
#8 | Pajukanta Paivi | 3 |
#9 | Ehnholm Christian | 3 |
#10 | Peltonen-Palotie Leena | 3 |
Publication | Filing date | Title |
---|---|---|
CA2559359A1 | Identification of snps associated with hyperlipidemia, dyslipidemia and defective carbohydrate metabolism | |
IL160151D0 | Identification of a dna variant associated with adult type hypolactasia | |
CN1541265A | Identification of DNA variant associated with adult type hypolactasia | |
US6951928B1 | Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED) |